{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-006083","form_type":"8-K/A","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.756037+00:00","generated_at":"2026-06-18T05:19:54.277550+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"DiaMedica appoints Tanya N. Lewis to Board and Compensation Committee","bullets":["Tanya N. Lewis appointed to DiaMedica Board effective March 1, 2023.","Lewis appointed to Compensation Committee effective March 9, 2023.","8-K/A filed to disclose committee membership previously undetermined.","No other changes from initial Form 8-K filed March 6, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-006083","json":"https://secwatch.observer/filing/0001437749-23-006083.json","markdown":"https://secwatch.observer/filing/0001437749-23-006083.md","text":"https://secwatch.observer/filing/0001437749-23-006083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/dmtp20230309_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:19:54.277550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b6e613b23","claim":"Tanya N. Lewis was appointed as Member of Compensation Committee at DiaMedica Therapeutics Inc..","evidence_excerpt":"On and effective March 9, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Lewis as a member of the Compensation Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Member of Compensation Committee"}],"fact_type":"executive_change"},{"claim_id":"ecf4111f2c","claim":"Tanya N. Lewis was appointed as Director at DiaMedica Therapeutics Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of the Company appointed Tanya N. Lewis to the Board, effective March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774923006083/0001437749-23-006083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}